Filing Details
- Accession Number:
- 0001209191-21-053378
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-25 19:35:17
- Reporting Period:
- 2021-08-23
- Accepted Time:
- 2021-08-25 19:35:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573072 | F David Novack | C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-13 | 2,500 | $3.39 | 109,899 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-08-23 | 4,167 | $4.50 | 114,066 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-24 | 10,000 | $14.00 | 104,066 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (Right to Buy) | Disposition | 2021-08-23 | 4,167 | $0.00 | 4,167 | $4.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-12 | No | 4 | M | Direct |
Footnotes
- Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 1, 2021.
- All shares were sold at $14.00
- Warrants were issued in connection with a financing transaction dated August 12, 2019 and were immediately exercisable upon issuance andhave an expiration date of February 12, 2022.
- Not applicable
Billionaire Hedge Funds
